We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Clorox Company (CLX - Free Report) reported first-quarter fiscal 2018 results, wherein adjusted earnings from continuing operations of $1.46 per share rose 7% year over year and also beat the Zacks Consensus Estimate of $1.41.
The company cut down its earnings guidance for fiscal 2018 in the range of $5.47-$5.67, compared with $5.52–$5.72 per share guided earlier. The current outlook includes an anticipated impact of 10 cents related to hurricanes.
Clorox Company (The) Price, Consensus and EPS Surprise
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.4%.
Revenues: Clorox generated net sales of $1,500 million that climbed 4% year over year, beating the Zacks Consensus Estimate of $1,478 million. The year over year increase was backed by volume growth of 4%, along with growth across all the segments.
The company now anticipates sales growth of 1-3% for fiscal 2018 versus increase of 2-4%, expected earlier. The guidance includes a slight reduction of less than 1 point from the divestiture of its Aplicare business.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Clorox (CLX) Tops Q1 Earnings & Sales, Cut Down FY18 View
The Clorox Company (CLX - Free Report) reported first-quarter fiscal 2018 results, wherein adjusted earnings from continuing operations of $1.46 per share rose 7% year over year and also beat the Zacks Consensus Estimate of $1.41.
The company cut down its earnings guidance for fiscal 2018 in the range of $5.47-$5.67, compared with $5.52–$5.72 per share guided earlier. The current outlook includes an anticipated impact of 10 cents related to hurricanes.
Clorox Company (The) Price, Consensus and EPS Surprise
Clorox Company (The) Price, Consensus and EPS Surprise | Clorox Company (The) Quote
Earnings Estimate Revision: The Zacks Consensus Estimate for the current fiscal has been trending down in the last 30 days. If we look at Clorox’s performance in the trailing four quarters (excluding the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.4%.
Revenues: Clorox generated net sales of $1,500 million that climbed 4% year over year, beating the Zacks Consensus Estimate of $1,478 million. The year over year increase was backed by volume growth of 4%, along with growth across all the segments.
The company now anticipates sales growth of 1-3% for fiscal 2018 versus increase of 2-4%, expected earlier. The guidance includes a slight reduction of less than 1 point from the divestiture of its Aplicare business.
Zacks Rank: Currently, Clorox carries a Zacks Rank #4 (Sell), which is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on Clorox’s earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>